Gemcitabine with carboplatin in metastatic breast cancer: Characterizing outcomes in a modern, real-world population.

Jordyn Paige Higgins,Chloe Lalonde,Kristina F. Byers,Christine C. Davis,Kandra Horne,Subir Goyal,Zhengjia Chen,Jane L. Meisel,Joan L. Kramer,Meagan Spencer Barbee

Gemcitabine with carboplatin in metastatic breast cancer: Characterizing outcomes in a modern, real-world population.

2020

Jordyn Paige Higgins
Chloe Lalonde
Kristina F. Byers
Christine C. Davis
Kandra Horne
Subir Goyal
Zhengjia Chen
Jane L. Meisel
Joan L. Kramer
Meagan Spencer Barbee

e13085Background: The specifics of the salvage regimen gemcitabine/carboplatin (G/C) in metastatic breast cancer (MBC) are not well-characterized and are limited to the clinical trial setting, whic...

Keywords:

Metastatic breast cancer
Oncology
Gemcitabine
World population
Internal medicine
Carboplatin
Pathology
Medicine
Clinical trial
salvage regimen

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations